ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.667,83
0,85%
S&P 500
6.032,38
0,56%
US Dollar vs BRL
5,97435
0,00%
Bitcoin
95.966,38
-0,49%
Brent Oil
71,98
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Pulmonx Corporation (LUNG)

  7. Pulmonx Corporation (LUNG) Notícias

LUNG

Pulmonx (LUNG)

Pulmonx Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:LUNG
DataHoraFonteTítuloCódigoCompanhia
26/11/202420:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
22/11/202418:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LUNGPulmonx Corporation
20/11/202418:05GlobeNewswire Inc.Pulmonx to Present at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:LUNGPulmonx Corporation
19/11/202411:00Business WirePulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and ProvidersNASDAQ:LUNGPulmonx Corporation
14/11/202421:47Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LUNGPulmonx Corporation
07/11/202418:05GlobeNewswire Inc.Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:LUNGPulmonx Corporation
05/11/202418:05GlobeNewswire Inc.Pulmonx to Present at the Stifel 2024 Healthcare ConferenceNASDAQ:LUNGPulmonx Corporation
01/11/202417:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUNGPulmonx Corporation
30/10/202417:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUNGPulmonx Corporation
30/10/202417:05GlobeNewswire Inc.Pulmonx Reports Third Quarter 2024 Financial ResultsNASDAQ:LUNGPulmonx Corporation
16/10/202417:05GlobeNewswire Inc.Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024NASDAQ:LUNGPulmonx Corporation
09/09/202417:05GlobeNewswire Inc.Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024NASDAQ:LUNGPulmonx Corporation
29/08/202417:05GlobeNewswire Inc.Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth ConferenceNASDAQ:LUNGPulmonx Corporation
22/08/202417:05GlobeNewswire Inc.Pulmonx to Present at the 2024 Wells Fargo Healthcare ConferenceNASDAQ:LUNGPulmonx Corporation
31/07/202417:05GlobeNewswire Inc.Pulmonx Reports Second Quarter 2024 Financial ResultsNASDAQ:LUNGPulmonx Corporation
29/07/202417:05GlobeNewswire Inc.Pulmonx to Present at the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:LUNGPulmonx Corporation
10/07/202417:05GlobeNewswire Inc.Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024NASDAQ:LUNGPulmonx Corporation
31/05/202417:38Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:LUNGPulmonx Corporation
06/05/202418:03GlobeNewswire Inc.Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LUNGPulmonx Corporation
01/05/202417:05GlobeNewswire Inc.Pulmonx Reports First Quarter 2024 Financial ResultsNASDAQ:LUNGPulmonx Corporation
10/04/202417:05GlobeNewswire Inc.Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024NASDAQ:LUNGPulmonx Corporation
02/04/202417:05GlobeNewswire Inc.Pulmonx Announces Appointment of Mehul Joshi as Chief Financial OfficerNASDAQ:LUNGPulmonx Corporation
07/03/202422:02Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:LUNGPulmonx Corporation
29/02/202418:31Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LUNGPulmonx Corporation
27/02/202418:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LUNGPulmonx Corporation
26/02/202422:48Business WirePulmonx meldet Behandlung des ersten Patienten mit dem AeriSeal®-System in der CONVERT-II-ZulassungsstudieNASDAQ:LUNGPulmonx Corporation
26/02/202422:40Business WirePulmonx annonce le traitement du premier patient par système AeriSeal® dans l'essai pivot CONVERT IINASDAQ:LUNGPulmonx Corporation
26/02/202422:39Business WirePulmonx annuncia il trattamento del primo paziente con il sistema AeriSeal® nello studio pivotale CONVERT IINASDAQ:LUNGPulmonx Corporation
26/02/202410:00Business WirePulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal TrialNASDAQ:LUNGPulmonx Corporation
21/02/202418:06GlobeNewswire Inc.Pulmonx Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LUNGPulmonx Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:LUNG

Seu Histórico Recente

TG
CWC
CEWE Stiftung and Co KGaA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Economize até 50%* para TRADER PLUS

1 ano 30%, 2 anos 40% e *3 anos 50%

*Ao longo de 3 anos $ 1475.65 apenas $ 737.82